AI assistant
BIO-TECHNE Corp — Director's Dealing 2022
Aug 9, 2022
30718_dirs_2022-08-09_e4bff110-f2b3-4150-b018-52afeed3a42a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2022-08-07
Reporting Person: Hippel James (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-08-07 | Common Stock | M | 3938 | — | Acquired | 14693 | Direct |
| 2022-08-07 | Common Stock | F | 1938 | $382.97 | Disposed | 12755 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-08-07 | Restricted Stock Units | $ | M | 3938 | Disposed | Common Stock (3938) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $125.0500 | 2024-08-09 | Common Stock (47389) | 47389 | Direct |
| Stock Options (Right to Buy) | $177.3200 | 2025-08-08 | Common Stock (18066) | 18066 | Direct |
| Stock Options (Right to Buy) | $177.3200 | 2025-08-08 | Common Stock (24089) | 24089 | Direct |
| Stock Options (Right to Buy) | $190.4100 | 2025-08-08 | Common Stock (24089) | 24089 | Direct |
| Stock Options (Right to Buy) | $190.4100 | 2026-08-07 | Common Stock (26581) | 26581 | Direct |
| Restricted Stock Units | $ | Common Stock (3219) | 3219 | Direct | |
| Stock Options (Right to Buy) | $267.8700 | 2027-08-05 | Common Stock (14360) | 14360 | Direct |
| Stock Options (Right to Buy) | $267.8700 | 2027-08-05 | Common Stock (19147) | 19147 | Direct |
| Stock Options (Right to Buy) | $267.8700 | 2027-08-05 | Common Stock (8325) | 8325 | Direct |
| Stock Options (Right to Buy) | $267.8700 | 2027-08-05 | Common Stock (8325) | 8325 | Direct |
| Restricted Stock Units | $ | Common Stock (1945) | 1945 | Direct | |
| Stock Options (Right to Buy) | $481.8200 | 2028-08-06 | Common Stock (7600) | 7600 | Direct |
| Stock Options (Right to Buy) | $481.8200 | 2028-08-06 | Common Stock (10134) | 10134 | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.
F2: Fully exercisable.
F3: On 8/7/22, the Board of Directors certified vesting of 3,938 performance RSUs.
F4: Options to purchase 6,646 shares vest on 8/7/2020 and options to purchase 6,645 shares vest on each of 8/7/2021, 8/7/2022 and 8/7/2023.
F5: Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F6: Options to purchase 4,787 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023 and options to purchase 4,786 shares vest on 8/5/2024.
F7: Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.
F8: Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
F9: Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F10: Options to purchase 2,534 shares vest on each of 8/6/2022 and 8/6/2023 and options to purchase 2,533 shares vest on each of 8/6/2024 and 8/6/2025.